WEC
ABMD

Winslow Evans & Crocker’s Abiomed Inc ABMD Stock Holding History

Winslow Evans & Crocker’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$4K Hold
12
– – ﹤0.01% 1164
2020
Q3 		$3K Hold
12
– – ﹤0.01% 984
2020
Q2 		$3K Hold
12
– – ﹤0.01% 1010
2020
Q1 		$2K Hold
12
– – ﹤0.01% 1102
2019
Q4 		$4K Hold
12
– – ﹤0.01% 1056
2019
Q3 		$4K Hold
12
– – ﹤0.01% 1043
2019
Q2 		$4K Buy
+12
New +$3.18K ﹤0.01% 1042
2017
Q1 		– Sell
-2,770
Closed -$312K – 1286
2016
Q4 		$312K Sell
2,770
-626
-18% -$72.5K 0.1% 215
2016
Q3 		$437K Buy
+3,396
New +$407K 0.13% 175

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Winslow Evans & Crocker's ABMD Position: Q4 2020 in Review

Winslow Evans & Crocker held its Abiomed Inc (ABMD) position steady in Q4 2020 at 12 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #1164.

Winslow Evans & Crocker first reported a position in ABMD in Q3 2016 and has held it in 9 quarters since. The position peaked at $437K in Q3 2016. 498 funds tracked by Wall St. Rank hold ABMD as of Q4 2020.

  • Winslow Evans & Crocker held 12 shares of Abiomed Inc worth $4K as of Q4 2020.
  • Winslow Evans & Crocker left its Abiomed Inc share count unchanged in Q4 2020.
  • Abiomed Inc made up ﹤0.01% of Winslow Evans & Crocker's portfolio in Q4 2020, its #1164 holding.
  • Winslow Evans & Crocker first reported a position in Abiomed Inc in Q3 2016 and has held it in 9 quarters since.
  • Winslow Evans & Crocker's Abiomed Inc position peaked at $437K in Q3 2016.
  • 498 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2020.

Based on Winslow Evans & Crocker's 13F filing for Q4 2020, filed 3 Feb 2021.